Abbvie Corporation v. Samsung Bioepis Co., Ltd., 2017 FC 675
Jurisdiction | Federal Jurisdiction (Canada) |
Subject Matter | CONTRACTS,INJUNCTIONS,PRACTICE |
Citation | 2017 FC 675 |
Court | Federal Court (Canada) |
Date | 12 July 2017 |
-
- This document is available in original version only for vLex customers
View this document and try vLex for 7 days - TRY VLEX
- This document is available in original version only for vLex customers
4 practice notes
-
Angelcare Development Inc. v. Munchkin, Inc., 2018 FC 447
...Peripheral Vascular Inc v WL Gore & Associates, Inc, 2017 FC 585 [Bard Peripheral] and Abbvie Corporation v Samsung Bioepis Co, Ltd, 2017 FC 675 [Abbvie Corp]. He found that in order to prevent disclosure to an in-house counsel, the Court must be presented with concrete evidence that es......
-
Paid Search Engine Tools, LLC v. Google Canada Corporation, 2019 FC 559
...affecting even outside counsel. [74] In this regard, I adopt Justice Manson’s reasoning in Abbvie Corporation v Samsung Bioepis Co Ltd, 2017 FC 675 at para 15, 282 ACWS (3d) 43: [15] Although Bioepis also argues that their commercial business or scientific interests may be seriously harmed ......
-
Proposed Prosecution Bar In Addition To Protective Order Denied Due To Insufficient Evidence (Intellectual Property Weekly Abstracts - Week of July 17, 2017)
...prosecution bar in addition to protective order denied due to insufficient evidence Abbvie Corporation v. Samsung Bioepis Co., Ltd., 2017 FC 675 Drug: In this case, AbbVie brought an application against Samsung pursuant to the NOC Regulations. The parties agreed that a protective order was ......
-
Proposed Prosecution Bar In Addition To Protective Order Denied Due To Insufficient Evidence (Intellectual Property Weekly Abstracts Bulletin Week of July 17, 2017)
...prosecution bar in addition to protective order denied due to insufficient evidence Abbvie Corporation v. Samsung Bioepis Co., Ltd., 2017 FC 675 Drug: In this case, AbbVie brought an application against Samsung pursuant to the NOC Regulations. The parties agreed that a protective order was ......
2 cases
-
Angelcare Development Inc. v. Munchkin, Inc., 2018 FC 447
...Peripheral Vascular Inc v WL Gore & Associates, Inc, 2017 FC 585 [Bard Peripheral] and Abbvie Corporation v Samsung Bioepis Co, Ltd, 2017 FC 675 [Abbvie Corp]. He found that in order to prevent disclosure to an in-house counsel, the Court must be presented with concrete evidence that es......
-
Paid Search Engine Tools, LLC v. Google Canada Corporation, 2019 FC 559
...affecting even outside counsel. [74] In this regard, I adopt Justice Manson’s reasoning in Abbvie Corporation v Samsung Bioepis Co Ltd, 2017 FC 675 at para 15, 282 ACWS (3d) 43: [15] Although Bioepis also argues that their commercial business or scientific interests may be seriously harmed ......
2 firm's commentaries
-
Proposed Prosecution Bar In Addition To Protective Order Denied Due To Insufficient Evidence (Intellectual Property Weekly Abstracts - Week of July 17, 2017)
...prosecution bar in addition to protective order denied due to insufficient evidence Abbvie Corporation v. Samsung Bioepis Co., Ltd., 2017 FC 675 Drug: In this case, AbbVie brought an application against Samsung pursuant to the NOC Regulations. The parties agreed that a protective order was ......
-
Proposed Prosecution Bar In Addition To Protective Order Denied Due To Insufficient Evidence (Intellectual Property Weekly Abstracts Bulletin Week of July 17, 2017)
...prosecution bar in addition to protective order denied due to insufficient evidence Abbvie Corporation v. Samsung Bioepis Co., Ltd., 2017 FC 675 Drug: In this case, AbbVie brought an application against Samsung pursuant to the NOC Regulations. The parties agreed that a protective order was ......